SEC Form 4 · accession 0001209191-15-048102
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Bain Thomas
Director
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 27, 2015 | A | 15,000 | $0.00 | A | 15,000 | D | |
| Common StockF2,F3,F4 | May 28, 2015 | P | 10,000 | $3.8461 | A | 55,000 | I | Rob Thomas Superannuation Fund |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units vest in full on the earlier of (i) May 27, 2016 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting.
- F2Represents the purchase of 100,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
- F3The purchase was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
- F4This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $3.75 to $3.91. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.